1. Home
  2. LGND vs RQI Comparison

LGND vs RQI Comparison

Compare LGND & RQI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LGND
  • RQI
  • Stock Information
  • Founded
  • LGND 1987
  • RQI 2002
  • Country
  • LGND United States
  • RQI United States
  • Employees
  • LGND N/A
  • RQI N/A
  • Industry
  • LGND Biotechnology: Pharmaceutical Preparations
  • RQI Trusts Except Educational Religious and Charitable
  • Sector
  • LGND Health Care
  • RQI Finance
  • Exchange
  • LGND Nasdaq
  • RQI Nasdaq
  • Market Cap
  • LGND 2.0B
  • RQI 1.7B
  • IPO Year
  • LGND 1992
  • RQI N/A
  • Fundamental
  • Price
  • LGND $102.19
  • RQI $12.46
  • Analyst Decision
  • LGND Strong Buy
  • RQI
  • Analyst Count
  • LGND 8
  • RQI 0
  • Target Price
  • LGND $144.71
  • RQI N/A
  • AVG Volume (30 Days)
  • LGND 118.3K
  • RQI 432.6K
  • Earning Date
  • LGND 05-08-2025
  • RQI 01-01-0001
  • Dividend Yield
  • LGND N/A
  • RQI 8.20%
  • EPS Growth
  • LGND N/A
  • RQI N/A
  • EPS
  • LGND N/A
  • RQI N/A
  • Revenue
  • LGND $181,488,000.00
  • RQI N/A
  • Revenue This Year
  • LGND $17.68
  • RQI N/A
  • Revenue Next Year
  • LGND $18.69
  • RQI N/A
  • P/E Ratio
  • LGND N/A
  • RQI N/A
  • Revenue Growth
  • LGND 53.40
  • RQI N/A
  • 52 Week Low
  • LGND $77.43
  • RQI $9.17
  • 52 Week High
  • LGND $129.90
  • RQI $12.64
  • Technical
  • Relative Strength Index (RSI)
  • LGND 44.63
  • RQI 56.08
  • Support Level
  • LGND $98.90
  • RQI $11.94
  • Resistance Level
  • LGND $103.17
  • RQI $12.29
  • Average True Range (ATR)
  • LGND 3.05
  • RQI 0.20
  • MACD
  • LGND -0.27
  • RQI 0.00
  • Stochastic Oscillator
  • LGND 31.94
  • RQI 82.54

About LGND Ligand Pharmaceuticals Incorporated

Ligand Pharmaceuticals Inc is a biopharmaceutical company focused on developing and acquiring technologies that aid in creating medicine. The company has partnerships and license agreements with various pharmaceutical and biotechnology companies. Ligand's business model is based on drug discovery, early-stage drug development, product reformulation, and partnerships. The company's revenue consists of three primary elements: royalties from commercialized products, license and milestone payments, and sale of its trademarked Captisol material.

About RQI Cohen & Steers Quality Income Realty Fund Inc

COHEN & STEERS QUALITY INCOME REALTY FUND INC is a diversified, closed-end management investment company. The primary investment objective of the Fund is high current income through investment in real estate securities. Its secondary objective is capital appreciation. The Fund invests at least its total assets in income-producing common stocks and other securities issued by real estate companies, such as real estate investment trusts under normal market conditions.

Share on Social Networks: